Keros Therapeutics, Inc. insider trading
KROS$11.36+0.10 (+0.89%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-27.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
- JSJasbir Seehra2.2227%
- JKJulius Knowles1.3277%
- RNRan Nussbaum0.7831%
- TKTomer Kariv0.7831%
- CRChristopher Rovaldi0.3026%
- ATAnnita Tanini0.2277%
- CLCarl L. Gordon0.2272%
- YHYung H. Chyung0.2219%
- KRKeith Regnante0.198%
- ECEsther Cho0.1804%
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| KROS | Annita Tanini | Open market sell$12.6K | -2.6% | $10.29 | $12.6K | Aug 18, 2026 | Aug 20, 2026 |
| KROS | Esther Cho | Open market sell$46.2K | -11.1% | $10.29 | $46.2K | Aug 18, 2026 | Aug 20, 2026 |
| KROS | Lorena Raquel Lerner | Open market sell$36.7K | -11.5% | $10.29 | $36.7K | Aug 18, 2026 | Aug 20, 2026 |
| KROS | Charles W. Newton | Open market sell$5.68K | -4.4% | $10.30 | $5.68K | Aug 18, 2026 | Aug 20, 2026 |
| KROS | Jean Jacques Bienaime | Open market purchase$10.3K | +5.4% | $10.27 | $10.3K | Aug 17, 2026 | Aug 19, 2026 |
| KROS | Jean Jacques Bienaime | Open market purchase$10.6K | +5.7% | $10.61 | $10.6K | Jul 15, 2026 | Jul 17, 2026 |
| KROS | Jean Jacques Bienaime | Open market purchase$10.2K | +6.0% | $10.19 | $10.2K | Jun 15, 2026 | Jun 17, 2026 |
| KROS | Charles W. Newton | Open market sell$5.52K | -4.2% | $10.04 | $5.52K | Jun 11, 2026 | Jun 15, 2026 |
| KROS | Julius Knowles | Open market sell$28.2K | -2.3% | $10.73 | $28.2K | Jun 4, 2026 | Jun 8, 2026 |
| KROS | Nima Farzan | Open market sell$28.2K | -21.2% | $10.73 | $28.2K | Jun 4, 2026 | Jun 8, 2026 |
| KROS | Alpna Seth | Open market sell$28.1K | -21.2% | $10.72 | $28.1K | Jun 4, 2026 | Jun 5, 2026 |
| KROS | Jean Jacques Bienaime | Open market purchase$10.6K | +11.8% | $10.58 | $10.6K | May 15, 2026 | May 19, 2026 |
| KROS | Jean Jacques Bienaime | Open market purchase$11.7K | +13.4% | $11.70 | $11.7K | Apr 15, 2026 | Apr 17, 2026 |
| KROS | Jean Jacques Bienaime | Open market purchase$22.4K | +36.7% | $11.21 | $22.4K | Mar 9, 2026 | Mar 11, 2026 |
| KROS | Jasbir Seehra | Open market sell$113K | -1.8% | $16.17 | $113K | Feb 19, 2026 | Feb 20, 2026 |
| KROS | Esther Cho | Open market sell$77.6K | -10.7% | $16.35 | $77.6K | Feb 18, 2026 | Feb 20, 2026 |
| KROS | Lorena Raquel Lerner | Open market sell$63.3K | -11.1% | $16.35 | $63.3K | Feb 18, 2026 | Feb 20, 2026 |
| KROS | Keith Regnante | Open market sell$77.5K | -10.8% | $16.35 | $77.5K | Feb 18, 2026 | Feb 20, 2026 |
| KROS | Pontifax (China) IV L.P. | Open market sell$2.76M | -93.7% | $17.75 | $2.76M | Oct 15, 2025 | Oct 17, 2025 |
| KROS | Pontifax (China) IV L.P. | Open market sell$21.8M | -99.2% | $17.75 | $21.8M | Oct 15, 2025 | Oct 17, 2025 |
| KROS | Pontifax (China) IV L.P. | Open market sell$19.9M | -99.1% | $17.75 | $19.9M | Oct 15, 2025 | Oct 17, 2025 |
| KROS | Pontifax (China) IV L.P. | Open market sell$40.6M | -99.5% | $17.75 | $40.6M | Oct 15, 2025 | Oct 17, 2025 |
| KROS | Daniel Schneeberger | Open market sell$13.2M | -100.0% | $17.75 | $13.2M | Oct 15, 2025 | Oct 15, 2025 |
| KROS | Daniel Schneeberger | Open market sell$4.52M | -100.0% | $17.75 | $4.52M | Oct 15, 2025 | Oct 15, 2025 |
| KROS | Daniel Schneeberger | Open market sell$77.9M | -100.0% | $17.75 | $77.9M | Oct 15, 2025 | Oct 15, 2025 |